Abstract
Health-related quality of life (HRQOL) in leukemia and lymphoma patients treated with high-dose chemotherapy followed by allogeneic (SCT) and autologous (ASCT) stem cell transplantation or receiving combination chemotherapy (CT) was prospectively assessed by the EORTC QLQ-C30 and compared with reference data from a general population sample. One year after transplant, the SCT group had functional scores which were close to population values except for lower social (P < 0.0001) and role function (P = 0.0004). More symptoms and problems were reported, especially appetite loss (P = 0.001) and financial difficulties (P = 0.0001). The ASCT patients reported a less than optimal HRQOL relative to the population 1 year post transplant. Cognitive, physical, role, and social function, dyspnoea, financial difficulties and global quality of life were most impaired (P < 0.001). in the ct group, physical, role and social function, dyspnoea and financial difficulties were impaired 1 year after start of chemotherapy, compared with the general population (P < 0.001). the eortc qlq-c30 was supplemented by a high-dose chemotherapy module, the hdc-19, at the 1-year assessment, but no consistent differences were found across groups. fifteen to 34% of the patients expressed fears of relapse and worries about future health, while 24–30% indicated no participation in sexual activities.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hjermstad, M., Holte, H., Evensen, S. et al. Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year?. Bone Marrow Transplant 24, 911–918 (1999). https://doi.org/10.1038/sj.bmt.1701998
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701998
Keywords
This article is cited by
-
Patient-reported cognitive function among hematopoietic stem cell transplant and cellular therapy patients: a scoping review
Quality of Life Research (2023)
-
The effect of hematopoietic stem cell transplantation on patient-reported subjective oral dryness: a systematic review focusing on prevalence, severity and distress
Supportive Care in Cancer (2023)
-
Comparison of quality of life and health behaviors in survivors of acute leukemia and the general population
Annals of Hematology (2019)
-
Sleep disruption among cancer patients following autologous hematopoietic cell transplantation
Bone Marrow Transplantation (2018)
-
Health-related quality of life in patients who develop bronchiolitis obliterans syndrome following allo-SCT
Bone Marrow Transplantation (2015)